-transparent.png){kind=logo}
The clinical homogeneity of myeloproliferative syndromes associated with a 5 q- marker can be contested, but nevertheless finds support in the 2 case reports we have cited. One of these observations of refractory anemia with partial myeloblastosis and 5 q- marker has shown a transformation into an acute myelomonocytic leukemia with clonal chromosomal evolution.
Related Publications
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
September 1983,
Cancer genetics and cytogenetics,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
March 2004,
Leukemia & lymphoma,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
July 1992,
Cancer,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
April 1994,
Leukemia,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
December 1986,
Cancer genetics and cytogenetics,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
July 1995,
American journal of hematology,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
January 1974,
Clinical genetics,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
January 2011,
Hematology. American Society of Hematology. Education Program,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
January 1996,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Verhest, and
F Lustman, and
M Wittek, and
F van Schoubroeck, and
J P Naets
February 2008,
Haematologica,
